To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.
Latest action (7 Feb 2025): Introduced
What this bill does
H.R. 1142 would amend the Public Health Service Act to require the Secretary of Health and Human Services to establish national drug adherence guidelines for medications covered under Medicare Part B and Part D. The stated goal of these guidelines is to achieve 90 percent patient adherence to prescribed drug regimens. In developing the guidelines, the Secretary would be directed to incorporate artificial intelligence and machine learning technologies and, where practicable, to promote the use of generic and biosimilar drugs rather than more expensive brand-name alternatives.
The bill primarily affects the Department of Health and Human Services, which would be tasked with creating and implementing these guidelines, as well as Medicare beneficiaries and the health care providers, pharmacies, and drug manufacturers involved in prescribing and dispensing Part B and D medications. The practical effects on patients, costs, or drug pricing are not specified in the bill text; it sets a policy goal and directs guideline development rather than establishing specific new programs, funding, or enforcement mechanisms.
The bill was introduced on February 7, 2025, by Rep. David Schweikert of Arizona and referred to the House Committee on Energy and Commerce. It has not yet been the subject of committee action, hearings, or a floor vote. As with most introduced bills, it would need to be approved by committee, pass the House and Senate, and be signed by the President to become law.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
This bill requires the Centers for Medicare & Medicaid Services (CMS) to establish drug adherence guidelines for covered drugs under Medicare so as to achieve an adherence rate of 90%. The CMS must incorporate artificial intelligence and machine-learning technologies and promote generics and biosimilars when developing the guidance.
Common questions
- What does H.R. 1142 do?
- H.R. 1142 would amend the Public Health Service Act to require the Secretary of Health and Human Services to establish national drug adherence guidelines for medications covered under Medicare Part B and Part D. The stated goal of these guidelines is to achieve 90 percent patient adherence to prescribed drug regimens. In developing the guidelines, the Secretary would be directed to incorporate artificial intelligence and machine learning technologies and, where practicable, to promote the use of generic and biosimilar drugs rather than more expensive brand-name alternatives. The bill primarily affects the Department of Health and Human Services, which would be tasked with creating and implementing these guidelines, as well as Medicare beneficiaries and the health care providers, pharmacies, and drug manufacturers involved in prescribing and dispensing Part B and D medications. The practical effects on patients, costs, or drug pricing are not specified in the bill text; it sets a policy goal and directs guideline development rather than establishing specific new programs, funding, or enforcement mechanisms. The bill was introduced on February 7, 2025, by Rep. David Schweikert of Arizona and referred to the House Committee on Energy and Commerce. It has not yet been the subject of committee action, hearings, or a floor vote. As with most introduced bills, it would need to be approved by committee, pass the House and Senate, and be signed by the President to become law.
- Has H.R. 1142 become law?
- Not yet. As of 7 Feb 2025, H.R. 1142 is introduced.
- Who sponsored H.R. 1142?
- H.R. 1142 was sponsored by Rep. David Schweikert [R-AZ1] (Republican-AZ), with 0 cosponsors.
- What's the latest action on H.R. 1142?
- Introduced (7 Feb 2025).
Related bills in Health
Expressing support for the designation of September 22, 2026, as “National Hispanic Nurses Day” and recognizing the National Association of Hispanic Nurses as the leading organization representing and advocating for Hispanic nurses.
Recognizing the importance of protecting continuous Medicaid coverage for individuals undergoing active cancer treatment.
Community Health Worker Access Act
A resolution supporting the designation of October 2026 as “Substance Use & Misuse Prevention Month” to raise awareness of substance use and misuse in the United States.
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.